ReviewMaterials today. Bio2025
Carbon dots: A promising tool for viral infection treatment.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green Synthesis of Graphene Quantum Dots (GQDs) and Carbon Dots (CDs) Mediated with Erythrina caffra for Potential Antiviral Properties Against SARS-CoV-2.Materials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, viruses have impacted health, economy, and mental well-being of all humankind. Several advanced treatments and vaccines have been developed to overcome this problem. With the advancements in nanoscience and technology in the biomedical field, nanomaterials are now widely used in detection, diagnosis, and therapy. Carbon dots (CDs) have gained significant attention because of their remarkable physical, chemical, and biological properties. The bioactive features of CDs obtained from natural sources, including their antibacterial, anticancer, antiviral, and antioxidant capabilities, have been investigated. However, a broad scope exists to expand these studies and resolve the ambiguity in understanding the associated mechanisms. Hence, it is worth gathering knowledge regarding the potential natural sources of CDs that can help fight novel viral infections. In this review, we begin with a brief introduction in the first section, followed by an overview of viral structure, life cycle, modes of host entry, and current treatment strategies in the second section. The third section discusses the emergence of novel viruses. In the fourth and fifth sections, we examine the application of nanotechnology in managing viral infections, with particular emphasis on the use of CDs and their potential as protective agents against viral diseases. Section six highlights the challenges and limitations associated with the clinical application of CDs. Finally, we summarize the key findings and discuss the future prospects of CDs in antiviral therapy. This review is intended to serve as a valuable reference for the development of innovative treatment strategies against various viral infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.